ClinicalTrials.Veeva

Menu

The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, Biomechanics, and Pain Intensity

Mayo Clinic logo

Mayo Clinic

Status

Begins enrollment in 10 months

Conditions

Greater Trochanter Pain Syndrome, Gluteus Medius Tendinopathy, Gluteus Minimus Tendinopathy
Lateral Hip Pain
Gluteus Medius Muscle Strength

Treatments

Device: Bilateral Shoe Insert
Other: Physical Therapy
Device: Unilateral neutral shoe insert

Study type

Interventional

Funder types

Other

Identifiers

NCT06891001
24-011290

Details and patient eligibility

About

We hypothesize that the addition of a unilateral neutral shoe insert combined with standard physical therapy (PT+SI) will have greater improvements in pain and function at 12 weeks and 6 months compared to physical therapy with sham inserts (PT+Sham) and physical therapy (PT) alone. In addition, we hypothesize that the addition of a neutral shoe insert in the involved limb will immediately improve biomechanics and pain with the single-leg stance test.

Enrollment

36 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subjects with a history of unilateral hip pain lasting more than three months.
  • Subjects with a VAS pain score of at least 3/10 localized to the lateral hip.
  • Subjects with pain with palpation to lateral hip.
  • Subjects with pain with either resisted hip abduction in relative adduction testing position and/or single leg stance test

Exclusion criteria

  • Subjects wearing custom foot orthoses at the time of recruitment.
  • Subjects who endorse current low back pain ≥ 3 on the NRS or lumbar radiculopathy
  • Subjects with a medical history of spinal or lower limb surgery in the past 6 months.
  • Subjects with a medical history of total joint replacement of hip, knee, or ankle on the symptomatic side
  • Subjects who have had a corticosteroid injection at the hip within the last 12 months;
  • Subjects demonstrating clinical signs and symptoms of intra-articular hip joint pathology with ≥ 3/10 groin pain including imaging confirmed significant labral tearing requiring surgery or osteoarthritis > 2 (mild) on Kellgren-Lawrence score on radiographs.
  • Subjects previously diagnosed with systemic inflammatory conditions; active cancer/malignant tumors; or neurological conditions that would affect gait
  • Subjects who have had physical therapy within the past 3 months for hip pain
  • If subjects are unable to commit to 12 weeks of therapy with one supervised session weekly
  • Subjects who have the intention to perform treatments outside of this study including, but not limited to, dry needling or acupuncture, extracorporeal shockwave, therapeutic ultrasound, a TENEX procedure, medication injection therapies, platelet-rich plasma injections, stem cell injections, and surgery.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

36 participants in 3 patient groups

Physical Therapy
Active Comparator group
Description:
This arm will undergo a standardized physical therapy protocol alone.
Treatment:
Other: Physical Therapy
Physical Therapy Plus Bilateral Shoe Insert
Sham Comparator group
Description:
This arm will undergo a standardized physical therapy protocol with the addition of a neutral shoe insert bilaterally.
Treatment:
Device: Bilateral Shoe Insert
Physical Therapy Plus Unilateral Shoe Insert
Experimental group
Description:
This arm will undergo a standardized physical therapy protocol with the addition of a neutral shoe insert on the involved side.
Treatment:
Device: Unilateral neutral shoe insert

Trial contacts and locations

1

Loading...

Central trial contact

Daniel McGurren, Doctorate of Physical Therapy; Daniel Cooper, Doctorate in Physical Therapy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems